Blobel, G
In vivo research protocols typically use lower doses, with careful attention to hypoglycemia risk
[DOI] [PMC free article] [PubMed] [Google Scholar] 7.Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbll T
The glucagon component, while contributing to enhanced metabolic benefits, poses a potential risk of hypoglycemia, necessitating precise dose titration to avoid adverse glycemic events
District Court for the District of South Carolina U.S
ALA preserve the enzyme activities of pyruvate dehydrogenase, and -ketoglutarate dehydrogenase through binding with amide linkage at lysine amino acid sites